Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Mylan Bertek Pharmaceuticals"
Count: 14
Selected: 0
NCT IDTitle
NCT00142584Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
NCT00145210Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans
NCT00200525Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease
NCT00200512Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months
NCT00200499A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients
NCT00200421A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension
NCT00200473A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients
NCT00200460A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients
NCT00200434A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension
NCT00145236Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension
NCT00158093A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo
NCT00145171A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.
NCT00142545Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease
NCT00634166Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group